title: Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
abstract: Adverse event following immunization (AEFI) is a critical component of immunization program. The risk of AEFI with vaccination is always weighed against the risk of not immunizing a child. There is an evolving AEFI surveillance system in India for the vaccines delivered through universal immunization program (UIP) of government sector, but the reporting remained suboptimal for long in the country, and there is almost no participation from private sector. The AEFI reporting from private sector will provide vital information on the safety of new and underutilized vaccines, not part of the UIP in India. The national guidelines are recently revised and updated. The Indian Academy of Pediatrics believes that pediatricians, especially in private sector have a crucial role to play with reporting of AEFI with newer/underutilized vaccines. Programmatic error, vaccine reaction, injection reactions, coincidental and unknown are the five broad categories of AEFI for programmatic purposes. The serious AEFIs (death, disability, cluster and hospitalization) need to be reported immediately and investigated in detail as per the laid down procedures. Once a serious AEFI happens, primary or urban health centre should be immediately informed by the pediatricians practicing in rural or urban areas, respectively. This advocacy paper from the academy provides guidelines to practitioners on how to report cases, and suggests ways for IAP members to help in ongoing efforts of the government in improving AEFI surveillance in the country. The details about the diagnosis and management of known/expected AEFI with UIP and newer vaccines shall be published later.
authors.affiliation: Advisory Committee on Vaccines and Immunization Practices, Indian Academy of Pediatrics Correspondence to: Dr Vipin M Vashishtha, Convener, IAP Advisory Committee on Vaccines and Immunization Practices (ACVIP), Mangla Hospital and Research Center, Shakti Chowk, Bijnor, Uttar Pradesh, 246 701, India. vipinipsita@gmail.com.
authors.forename: A J
authors.initials: AJ
authors.lastname: Chitkara
authors.forename: N
authors.initials: N
authors.lastname: Thacker
authors.forename: V M
authors.initials: VM
authors.lastname: Vashishtha
authors.forename: C P
authors.initials: CP
authors.lastname: Bansal
authors.forename: S G
authors.initials: SG
authors.lastname: Gupta
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D007194:India; D011159:Population Surveillance / Q000379:methods; D014611:Vaccination / Q000009:adverse effects / Q000706:statistics & numerical data; D014612:Vaccines / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D014612:Vaccines